Conclusion
The outcomes of EVAR patient in the current study demonstrates safety
and acceptable durability of the endografts at AAA patients at five
years with survival rate over 60% and freedom from secondary
intervention exceeding 80%. Large aneurysms, low ejection fraction,
poor renal function and anemia are independent predictors of reduced
survival after endovascular repair of aneurysm. Longer-term follow-up is
expected to be reported through 10-years.